May 17 (SeeNews) - Croatian pharmaceuticals producer Jadran Galenski Laboratorij (JGL) [ZSE:3JDG2] said it redeemed early on April 24 2.0 million kuna ($287,000/265,446 euro) worth out of its 130 million kuna five-year bond issue maturing next year.
The maturity date of the remaining principal in the amount of 128 million kuna remains unchanged, JGL said in a filing to the Zagreb Stock Exchange.
According to bourse data, the transaction on April 24 was carried out at a price of 94.85 euro per bond.
The kuna-denominated bond was issued on December 19, 2019 and will mature on December 19, 2024, according to bourse data.
Founded in 1991, JGL is one of the largest drug makers in Croatia, specialising in the production of sterile nose, eye and ear drop solutions. JGL operates in some 60 markets around the world.
($ = 0.923 euro)